Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.
Dew
M A
MA
Dept. of Psychiatry, University of Pittsburgh, PA 15213.
Harris
R C
RC
Simmons
R G
RG
Roth
L H
LH
Armitage
J M
JM
Griffith
B P
BP
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006304:Health Status; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology* / Q000523:psychology*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011241:Prednisone / Q000627:therapeutic use; D011788:Quality of Life; D016559:Tacrolimus / Q000627:therapeutic use*
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus